Infinity Pharma (INFI) Misses Q1 EPS by 23c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Infinity Pharma (INFI) Misses Q1 EPS by 23c

Infinity Pharmaceutical (INFI) PT Cut to $13 at Nomura Securities

May 7, 2015 9:46 AM EDT

Nomura Securities analyst M. Ian Somaiya lowered its price target on Infinity Pharmaceutical (NASDAQ: INFI) to $13.00 (from $17.00) while reiterating a Neutral rating.

Somaiya commented, "We believe Infinity is building a comprehensive development plan for duvelisib, following its strategic partnership with AbbVie... More

Deutsche Bank Starts Infinity Pharmaceutical (INFI) at Buy

May 7, 2015 6:57 AM EDT

Deutsche Bank initiated coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Buy rating and a price target of $20.00. Analyst Robyn Karnauskas sees a place for Duvelisib in the iNHL &and CL markets.

"Infinity is developing Duvelisib in various blood cancers. We... More